MARKET

HOTH

HOTH

Hoth Therapeutics Inc
NASDAQ
0.9526
-0.0164
-1.69%
After Hours: 0.9500 -0.0026 -0.27% 17:54 05/09 EDT
OPEN
0.9835
PREV CLOSE
0.9690
HIGH
0.9835
LOW
0.9223
VOLUME
115.88K
TURNOVER
--
52 WEEK HIGH
3.800
52 WEEK LOW
0.5800
MARKET CAP
12.55M
P/E (TTM)
-0.7417
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HOTH last week (0428-0502)?
Weekly Report · 5d ago
Weekly Report: what happened at HOTH last week (0421-0425)?
Weekly Report · 04/28 11:54
Weekly Report: what happened at HOTH last week (0414-0418)?
Weekly Report · 04/21 11:54
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 04/17 21:05
Hoth Therapeutics granted Japanese patent for novel RNA-based cancer therapy
TipRanks · 04/17 12:06
Hoth Therapeutics Granted Japanese Patent Expanding Global Intellectual Property Portfolio In RNA-based Cancer Therapeutics
Benzinga · 04/17 12:04
Hoth Therapeutics Is Maintained at Buy by D. Boral Capital
Dow Jones · 04/15 14:43
Hoth Therapeutics Price Target Maintained With a $5.00/Share by D. Boral Capital
Dow Jones · 04/15 14:43
More
About HOTH
More
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). Its development products include HT-001, HT-KIT, HT-ALZ, and HT-TBI. Its BioLexa Platform is a proprietary, patented, drug compound platform for the treatment of eczema. The Company also has interests in certain other assets being developed by third parties including a treatment for patients with lupus.
Recently
Symbol
Price
%Change

Webull offers Hoth Therapeutics Inc stock information, including NASDAQ: HOTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HOTH stock methods without spending real money on the virtual paper trading platform.